down arrow

Natural Capsules

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE936B01015
  • NSEID: NATCAPSUQ
  • BSEID: 524654
INR
212.10
0.55 (0.26%)
BSENSE

Apr 11, 12:46 PM

BSE+NSE Vol: 3.37 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

3.37 k (-65.99%) Volume

Shareholding (Feb 2025)

FII

0.00%

Held by 0 FIIs

DII

0.00%

Held by 0 DIIs

Promoter

51.14%

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Dashboard
1

Poor Management Efficiency with a low ROCE of 9.29%

  • The company has been able to generate a Return on Capital Employed (avg) of 9.29% signifying low profitability per unit of total capital (equity and debt)
2

The company has declared Negative results for the last 8 consecutive quarters

3

Stock is technically in a Bearish range

4

Consistent Underperformance against the benchmark over the last 3 years

stock-summaryMojo Parameters
Mojo Parameters
Loading Valuation Snapshot...
Stock DNA
stock-summary
Industry

Pharmaceuticals & Drugs

stock-summary
Market cap

INR 221 Cr (Micro Cap)

stock-summary
P/E

204.00

stock-summary
Industry P/E

33

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

0.37

stock-summary
Return on Equity

0.93%

stock-summary
Price to Book

0.94

Revenue and Profits (1 Year):
Net Sales:
44 Cr
(Quarterly Results - Dec 2024)
Net Profit:
0 Cr
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0%)
TimePeriod
Price Return
Dividend Return
Total Return
6 Months
-31.54%
0%
-31.54%
1 Year
-35.34%
0%
-35.34%
2 Years
-48.8%
0.22%
-48.58%
3 Years
-53.41%
0.43%
-52.98%
4 Years
82.06%
2.25%
84.31%
5 Years
436.96%
8.40%
445.36%

Latest dividend: 1 per share ex-dividend date: Jul-20-2023

Risk Adjusted Returns v/s Sensex stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
21.64%
EBIT Growth (5y)
36.91%
EBIT to Interest (avg)
5.92
Debt to EBITDA (avg)
2.56
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
0.89
Tax Ratio
68.17%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
10.29%
ROE (avg)
8.89%
Valuation key factors
Factor
Value
P/E Ratio
204
Industry P/E
33
Price to Book Value
0.94
EV to EBIT
37.68
EV to EBITDA
17.66
EV to Capital Employed
0.95
EV to Sales
1.85
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
2.72%
ROE (Latest)
0.93%
Tecnicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Mildly Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Bearish
Dow Theory
No Trend
No Trend
OBV
No Trend
Bullish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Feb 2025stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 0 Schemes

FIIs

Held by 0 FIIs

Promoter with highest holding

Tajos Investments Private Limited (12.12%)

Highest Public shareholder

Tarinika Management Llp (3.22%)

Individual Investors Holdings

32.86%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Dec'24 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Dec 2024 is 6.33% vs 5.21% in Sep 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Dec 2024 is 118.03% vs -201.67% in Sep 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "43.83",
          "val2": "41.22",
          "chgp": "6.33%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "4.27",
          "val2": "4.50",
          "chgp": "-5.11%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "1.54",
          "val2": "1.65",
          "chgp": "-6.67%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "0.11",
          "val2": "-0.61",
          "chgp": "118.03%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "9.74%",
          "val2": "10.92%",
          "chgp": "-1.18%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Consolidated) - Sep'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": " Growth in half year ended Sep 2024 is 6.91% vs -15.73% in Sep 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": " Growth in half year ended Sep 2024 is -100.30% vs -67.93% in Sep 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Sep'24",
        "Sep'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "80.41",
          "val2": "75.21",
          "chgp": "6.91%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "8.87",
          "val2": "11.07",
          "chgp": "-19.87%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "3.13",
          "val2": "2.50",
          "chgp": "25.20%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-0.01",
          "val2": "3.38",
          "chgp": "-100.30%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "11.03%",
          "val2": "14.72%",
          "chgp": "-3.69%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is 7.86% vs -14.52% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is -97.82% vs -70.93% in Dec 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "124.24",
          "val2": "115.19",
          "chgp": "7.86%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "13.14",
          "val2": "15.79",
          "chgp": "-16.78%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "4.67",
          "val2": "3.74",
          "chgp": "24.87%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "0.10",
          "val2": "4.59",
          "chgp": "-97.82%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "10.58%",
          "val2": "13.71%",
          "chgp": "-3.13%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Mar'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2024 is -9.83% vs 27.62% in Mar 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2024 is -69.92% vs 32.64% in Mar 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'24",
        "Mar'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "155.42",
          "val2": "172.37",
          "chgp": "-9.83%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "19.92",
          "val2": "35.04",
          "chgp": "-43.15%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "5.13",
          "val2": "3.41",
          "chgp": "50.44%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "5.55",
          "val2": "18.45",
          "chgp": "-69.92%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "12.82%",
          "val2": "20.33%",
          "chgp": "-7.51%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Dec'24 - QoQstock-summary
Dec'24
Sep'24
Change(%)
Net Sales
43.83
41.22
6.33%
Operating Profit (PBDIT) excl Other Income
4.27
4.50
-5.11%
Interest
1.54
1.65
-6.67%
Exceptional Items
0.00
0.00
Consolidate Net Profit
0.11
-0.61
118.03%
Operating Profit Margin (Excl OI)
9.74%
10.92%
-1.18%
Values in Rs Cr.
Direction Arrows
Net Sales

QoQ Growth in quarter ended Dec 2024 is 6.33% vs 5.21% in Sep 2024

Direction Arrows
Consolidated Net Profit

QoQ Growth in quarter ended Dec 2024 is 118.03% vs -201.67% in Sep 2024

Half Yearly Results Snapshot (Consolidated) - Sep'24stock-summary
Sep'24
Sep'23
Change(%)
Net Sales
80.41
75.21
6.91%
Operating Profit (PBDIT) excl Other Income
8.87
11.07
-19.87%
Interest
3.13
2.50
25.20%
Exceptional Items
0.00
0.00
Consolidate Net Profit
-0.01
3.38
-100.30%
Operating Profit Margin (Excl OI)
11.03%
14.72%
-3.69%
Values in Rs Cr.
Direction Arrows
Net Sales

Growth in half year ended Sep 2024 is 6.91% vs -15.73% in Sep 2023

Direction Arrows
Consolidated Net Profit

Growth in half year ended Sep 2024 is -100.30% vs -67.93% in Sep 2023

Nine Monthly Results Snapshot (Consolidated) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
124.24
115.19
7.86%
Operating Profit (PBDIT) excl Other Income
13.14
15.79
-16.78%
Interest
4.67
3.74
24.87%
Exceptional Items
0.00
0.00
Consolidate Net Profit
0.10
4.59
-97.82%
Operating Profit Margin (Excl OI)
10.58%
13.71%
-3.13%
Values in Rs Cr.
Direction Arrows
Net Sales

YoY Growth in nine months ended Dec 2024 is 7.86% vs -14.52% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in nine months ended Dec 2024 is -97.82% vs -70.93% in Dec 2023

Annual Results Snapshot (Consolidated) - Mar'24stock-summary
Mar'24
Mar'23
Change(%)
Net Sales
155.42
172.37
-9.83%
Operating Profit (PBDIT) excl Other Income
19.92
35.04
-43.15%
Interest
5.13
3.41
50.44%
Exceptional Items
0.00
0.00
Consolidate Net Profit
5.55
18.45
-69.92%
Operating Profit Margin (Excl OI)
12.82%
20.33%
-7.51%
Values in Rs Cr.
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2024 is -9.83% vs 27.62% in Mar 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Mar 2024 is -69.92% vs 32.64% in Mar 2023

stock-summaryCompany CV
About Natural Capsules Ltd stock-summary
stock-summary
Natural Capsules Ltd
Micro Cap
Pharmaceuticals & Drugs
Natural Capsules Limited was incorporated as Public Limited Company established in 1993 at Bangalore. The Company is one of the leading manufacturers of hard capsule shells in India. The Company introduced vegetarian capsules to Indian market and is the second-largest manufacturer of gelatin capsules in the country. NCL expanded its operations to Puducherry in 2003, further solidifying its position as a trusted brand in the industry.
Company Coordinates stock-summary
Company Details
Trident Towers 4th Floor No 23, 100Feet Road Jayanagar IIBlock Bangalore Karnataka : 560011
stock-summary
Tel: 91-080-26671571/26671573/26671581
stock-summary
company.sec@naturalcapsules.com
Registrar Details
Cameo Corporate Services Ltd , Subramanian Buildings No 1 , Club House Road, Chennai